Md Feroz Hossain

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Md Feroz Hossain is an author at The University of Texas MD Anderson Cancer Center specializing in acute leukemia chemotherapy, study phase, and refractory acute myeloid leukemia.

Publications per year

2022–2022

Publications

Phase Ib/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination with the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib in IDH Mutated Acute Myeloid Leukemia

Himachandana Atluri, Abhishek Maiti, Koji Sasaki et al. · Blood · 2022 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–1 of 1